BioCentury
ARTICLE | Company News

Pfizer sales and marketing update

May 6, 2013 7:00 AM UTC

Pfizer said India's Intellectual Property Appellate Board (IPAB) issued an order on April 5 to stay the revocation of the patent for cancer drug Sutent sunitinib until May 13, the date of the continuation hearing on the merits of the revocation. The pharma declined to disclose details. ...